Decision Appropriately Balances Access to Treatment with the Need for More Data on the Clinical Value for Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in reaction to the finalized National Coverage Determination decision for monoclonal antibodies for the treatment of Alzheimer’s from the U.S. Centers for Medicare & […]
Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable Following Another State of the Union Call for Action Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden once again calling for Congress to advance solutions to lower out-of-control drug prices and hold Big Pharma […]
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Competition, Transparency and Value Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the U.S. Senate confirmation of Dr. Robert M. Califf to serve as commissioner of the U.S. Food and Drug Administration (FDA). “CSRxP congratulates Dr. Califf […]
Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Drug Prices and Support Market-Based Solutions to Boost Affordability, Competition and Value Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult today. “Voters overwhelmingly view out-of-control prescription drug prices as a top political issue in […]
Drug Companies Increased Prices on 785 Brand Name Products in First Month of 2022 Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to pharmaceutical industry price hikes on 785 brand name drugs in the first month of 2022 by an average of 4.9 percent. “Throughout the COVID-19 pandemic, Big Pharma […]
Next FDA Commissioner Must Promote Competition, Transparency And Value In The Pharmaceutical Marketplace Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) executive session to consider the nomination of Dr. Robert M. Califf to serve as commissioner of the […]
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers to Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to Big Pharma increasing prices on 434 brand name drugs in just the first few days of 2022 — as part of biennial, traditional price hikes. […]
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s Pricing Practices Are “Unsustainable, Unjustifiable and Unfair” Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to a new report from the U.S. House Committee on Oversight and Reform examining Big Pharma’s pricing and business practices. “CSRxP applauds […]
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices, Reject Pharma-Backed Policies That Would Hike Health Care Premiums Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to the U.S. House passage of drug pricing provisions contained in the Build Back Better Act. “CSRxP applauds House lawmakers […]
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by $21.60 next year. According to Bloomberg Government, “Medicare […]